Clinical trial
Secondary Prevention of Small Subcortical Strokes Trial
NCT00059306 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00059306 |
|---|---|
| Title | Secondary Prevention of Small Subcortical Strokes Trial |
| Official title | Secondary Prevention of Small Subcortical Strokes (SPS3) Trial |
| Acronym | SPS3 |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident, Hypertension |
| Intervention type | Drug, Other |
| Interventions | aspirin, clopidogrel, Target of Blood Pressure, placebo |
| Enrollment | 3,020 |
| Start date | Feb 1, 2003 |
| Primary completion | Apr 1, 2012 |
| Completion | Apr 1, 2012 |
| First posted | Apr 24, 2003 |
| Last update posted | Apr 4, 2013 |
| Countries | Canada, Chile, Ecuador, Mexico, Peru, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: